ALCOR — Biocorp Production SA Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeSmall Cap
- €154.39m
- €157.50m
- €11.67m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.89 | 8.45 | 8.46 | 10.2 | 11.7 |
Cost of Revenue | |||||
Gross Profit | 3.1 | 8.6 | 7.66 | 9.94 | 10.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.21 | 7.49 | 9.8 | 10 | 12.5 |
Operating Profit | -5.32 | 0.956 | -1.34 | 0.193 | -0.853 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.64 | 0.798 | -1.49 | 0.096 | -0.91 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.31 | 0.96 | -1.24 | 0.294 | -0.651 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.31 | 0.96 | -1.24 | 0.294 | -0.651 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.31 | 0.96 | -1.24 | 0.294 | -0.651 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.31 | 0.22 | -0.326 | 0.06 | -0.131 |
Dividends per Share |